|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DYN | Kerr Douglas | Officer | Dec 05 '25 | Proposed Sale | 20.72 | 880 | 18,231 | Dec 05 04:56 PM | |
| DYN | Kerr Douglas | Chief Medical Officer | Dec 05 '25 | Sale | 20.72 | 880 | 18,234 | 87,510 | Dec 05 04:09 PM |
| DYN | Kerr Douglas | Chief Medical Officer | Sep 04 '25 | Sale | 13.27 | 3,552 | 47,135 | 89,263 | Sep 08 04:03 PM |
| DYN | Kerr Douglas | Chief Medical Officer | Sep 05 '25 | Sale | 13.41 | 873 | 11,707 | 88,390 | Sep 08 04:03 PM |
| DYN | Kerr Douglas | Officer | Sep 04 '25 | Proposed Sale | 13.27 | 4,552 | 60,402 | Sep 04 04:45 PM | |
| DYN | Kerr Douglas | Chief Medical Officer | Jun 05 '25 | Sale | 13.35 | 1,342 | 17,916 | 92,815 | Jun 06 04:05 PM |
| DYN | Kerr Douglas | Officer | Jun 05 '25 | Proposed Sale | 13.35 | 1,342 | 17,911 | Jun 05 04:13 PM | |
| DYN | Kerr Douglas | Chief Medical Officer | Mar 05 '25 | Sale | 11.83 | 1,343 | 15,888 | 94,157 | Mar 07 04:08 PM |
| DYN | Kerr Douglas | Officer | Mar 05 '25 | Proposed Sale | 11.89 | 1,343 | 15,968 | Mar 05 04:10 PM | |
| GBIO | Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 08 '21 | Sale | 25.20 | 3,518 | 88,670 | 326,558 | Jul 12 04:02 PM |
| GBIO | Kerr Douglas | CHIEF MEDICAL OFFICER | Apr 05 '21 | Sale | 30.09 | 14,072 | 423,451 | 326,558 | Apr 07 04:05 PM |
| GBIO | Kerr Douglas | CHIEF MEDICAL OFFICER | Mar 05 '21 | Sale | 31.44 | 11,267 | 354,267 | 326,558 | Mar 09 04:05 PM |
| GBIO | Kerr Douglas | CHIEF MEDICAL OFFICER | Feb 08 '21 | Sale | 33.37 | 11,267 | 375,954 | 326,558 | Feb 10 04:05 PM |
| GBIO | Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 11 '21 | Sale | 27.58 | 11,267 | 310,768 | 326,558 | Jan 13 04:07 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite